|
English
|
正體中文
|
简体中文
|
总笔数 :2822924
|
|
造访人次 :
30058014
在线人数 :
1030
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
"szima b"的相关文件
显示项目 1-4 / 4 (共1页) 1 每页显示[10|25|50]项目
臺大學術典藏 |
2022-06-27T07:01:52Z |
A correlative biomarker analysis of the combination of bevacizumab and carboplatin-based chemotherapy for advanced nonsquamous non-small-cell lung cancer: Results of the phase II randomized ABIGAIL study (BO21015)
|
Mok T.; Gorbunova V.; Juhasz E.; Szima B.; Burdaeva O.; Orlov S.; CHONG-JEN YU; Archer V.; Hilton M.; Delmar P.; Pallaud C.; Reck M. |
臺大學術典藏 |
2022-06-27T07:01:46Z |
Clinical genotyping and efficacy outcomes: Exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer
|
Pallaud C.; Reck M.; Juhasz E.; Szima B.; CHONG-JEN YU; Burdaeva O.; Orlov S.; Hilton M.; Archer V.; Mok T. |
國立臺灣大學 |
2012 |
TUMOUR BIOMARKER AND PLASMA TIME COURSE DATA FROM ABIGAIL, A PHASE II STUDY OF 1ST-LINE BEVACIZUMAB plus CHEMOTHERAPY IN ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER (NS-NSCLC)
|
Reck, M.; Gorbunova, V. A.; Juhasz, E.; Szima, B.; Orlov, S.; Yu, C.; Pallaud, C.; Scherer, S. J.; Archer, V.; Mok, T. S. K. |
國立臺灣大學 |
2012 |
CLINICAL GENOTYPING AND EFFICACY OUTCOMES: EXPLORATORY BIOMARKER DATA FROM THE PHASE II ABIGAIL STUDY OF 1ST-LINE BEVACIZUMAB plus CHEMOTHERAPY IN NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER (NS-NSCLC)
|
Pallaud, C.; Reck, M.; Juhasz, E.; Szima, B.; Yu, C.; Burdaeva, O.; Orlov, S.; Scherer, S. J.; Archer, V.; Mok, T. S. K. |
显示项目 1-4 / 4 (共1页) 1 每页显示[10|25|50]项目
|